<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31661037</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2051-5960</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>28</Day></PubDate></JournalIssue><Title>Acta neuropathologica communications</Title><ISOAbbreviation>Acta Neuropathol Commun</ISOAbbreviation></Journal><ArticleTitle>Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions.</ArticleTitle><Pagination><StartPage>165</StartPage><MedlinePgn>165</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">165</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40478-019-0824-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is characterized pathologically by the occurrence of phosphorylated TDP-43 (pTDP-43)-immunoreactive neuronal and glial inclusions in the central nervous system. Recent studies have shown that pTDP-43 aggregates also occur in the skeletal muscles in a certain proportion of ALS patients.</AbstractText><AbstractText Label="AIM">The aim of this study was to clarify the distribution and incidence of pTDP-43 aggregates in the skeletal and cardiac muscles of patients with ALS, and also those of patients with neuromuscular diseases (NMDs) and non-NMDs.</AbstractText><AbstractText Label="MATERIAL AND METHODS">Five regions of muscle (tongue, cervical muscle, diaphragm, iliopsoas muscle and heart) were examined histologically and immunohistochemically in patients with ALS (n&#x2009;=&#x2009;30), NMDs (n&#x2009;=&#x2009;13) and non-NMDs (n&#x2009;=&#x2009;7).</AbstractText><AbstractText Label="RESULTS">Two types of pTDP-43 aggregates were distinguishable morphologically: dense filamentous and short linear inclusions. These inclusions were found in at least one of the five muscle regions in all 30 cases of ALS; skeletal muscles in 28 cases and myocardium in 12. pTDP-43 aggregates were also found in 9 of 13 patients with NMDs, including myositis, muscular dystrophy and mitochondrial myopathy, as well as in 3 of 7 patients with non-NMDs. In ALS, pTDP-43 aggregates were most frequent in the diaphragm (19 cases). The mean density of pTDP-43 aggregates in ALS was significantly higher than that in NMDs and non-NMDs. In contiguous sections stained with hematoxylin and eosin and anti-pTDP-43, muscle fibers with dense filamentous inclusions demonstrated single-fiber atrophy with vacuolar degeneration.</AbstractText><AbstractText Label="CONCLUSION">The present findings indicate that pTDP-43 aggregates in skeletal and cardiac muscle are a myogenic pathological marker in multiple diseases including ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mori</LastName><ForeName>Fumiaki</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-1903-1766</Identifier><AffiliationInfo><Affiliation>Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562, Japan. neuropal@hirosaki-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tada</LastName><ForeName>Mari</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kon</LastName><ForeName>Tomoya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miki</LastName><ForeName>Yasuo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanji</LastName><ForeName>Kunikazu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurotaki</LastName><ForeName>Hidekachi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pathology, Aomori Prefectural Central Hospital, Aomori, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomiyama</LastName><ForeName>Masahiko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishihara</LastName><ForeName>Tomohiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Molecular Neuroscience, Brain Research Institute, Niigata University, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onodera</LastName><ForeName>Osamu</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kakita</LastName><ForeName>Akiyoshi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wakabayashi</LastName><ForeName>Koichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>17K07088</GrantID><Agency>JSPS KAKENHI</Agency><Country>International</Country></Grant><Grant><GrantID>17K07089</GrantID><Agency>JSPS KAKENHI</Agency><Country>International</Country></Grant><Grant><GrantID>18H02533</GrantID><Agency>JSPS KAKENHI</Agency><Country>International</Country></Grant><Grant><GrantID>2019</GrantID><Agency>Hirosaki University Institutional Research Grant</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Neuropathol Commun</MedlineTA><NlmUniqueID>101610673</NlmUniqueID><ISSNLinking>2051-5960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Myocardium</Keyword><Keyword MajorTopicYN="N">Myogenic degeneration</Keyword><Keyword MajorTopicYN="N">Skeletal muscle</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31661037</ArticleId><ArticleId IdType="pmc">PMC6816170</ArticleId><ArticleId IdType="doi">10.1186/s40478-019-0824-1</ArticleId><ArticleId IdType="pii">10.1186/s40478-019-0824-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Sarraj S, King A, Cleveland M, Pradat PF, Corse A, Rothstein JD, Leigh PN, Abila B, Bates S, Wurthner J, et al. Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study. Acta Neuropathol Commun. 2014;2:165. doi: 10.1186/s40478-014-0165-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-014-0165-z</ArticleId><ArticleId IdType="pmc">PMC4297389</ArticleId><ArticleId IdType="pubmed">25510661</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Badadani M, Nalbandian A, Watts GD, Vesa J, Kitazawa M, Su H, Tanaja J, Dec E, Wallace DC, Mukherjee J, et al. VCP associated inclusion body myopathy and paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. PLoS One. 2010;5:e13183. doi: 10.1371/journal.pone.0013183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013183</ArticleId><ArticleId IdType="pmc">PMC2950155</ArticleId><ArticleId IdType="pubmed">20957154</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortese A, Laura M, Casali C, Nishino I, Hayashi YK, Magri S, Taroni F, Stuani C, Saveri P, Moggio M, et al. Altered TDP-43-dependent splicing in HSPB8-related distal hereditary motor neuropathy and myofibrillar myopathy. Eur J Neurol. 2018;25:154&#x2013;163. doi: 10.1111/ene.13478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13478</ArticleId><ArticleId IdType="pubmed">29029362</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V, Boncoraglio A, Galbiati M, Aggarwal T, Rusmini P, Giorgetti E, Cristofani R, Carra S, Pennuto M, Poletti A. Differential autophagy power in the spinal cord and muscle of transgenic ALS mice. Front Cell Neurosci. 2013;7:234. doi: 10.3389/fncel.2013.00234.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00234</ArticleId><ArticleId IdType="pmc">PMC3840302</ArticleId><ArticleId IdType="pubmed">24324403</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski MD, Powell SZ, Appel JW, Arumanayagam AS, Rivera AL, Appel SH. Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2018;6:28. doi: 10.1186/s40478-018-0528-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0528-y</ArticleId><ArticleId IdType="pmc">PMC5899326</ArticleId><ArticleId IdType="pubmed">29653597</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Agostino C, Nogalska A, Engel WK, Askanas V. In sporadic inclusion body myositis muscle fibres TDP-43-positive inclusions are less frequent and robust than p62 inclusions, and are not associated with paired helical filaments. Neuropathol Appl Neurobiol. 2011;37:315&#x2013;320. doi: 10.1111/j.1365-2990.2010.01108.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2010.01108.x</ArticleId><ArticleId IdType="pubmed">20626631</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez Lain A, Millecamps S, Dubourg O, Salachas F, Bruneteau G, Lacomblez L, LeGuern E, Seilhean D, Duyckaerts C, Meininger V, et al. Abnormal TDP-43 and FUS proteins in muscles of sporadic IBM: similarities in a TARDBP-linked ALS patient. J Neurol Neurosurg Psychiatry. 2011;82:1414&#x2013;1416. doi: 10.1136/jnnp.2010.208868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.208868</ArticleId><ArticleId IdType="pubmed">20562395</ArticleId></ArticleIdList></Reference><Reference><Citation>Kierdaszuk B, Berdynski M, Palczewski P, Golebiowski M, Zekanowski C, Kaminska AM. Sporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients. Folia Neuropathol. 2015;53:355&#x2013;366. doi: 10.5114/fn.2015.56550.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/fn.2015.56550</ArticleId><ArticleId IdType="pubmed">26785370</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;sters B, van Hoeve BJ, Schelhaas HJ, Ter Laak H, van Engelen BG, Lammens M. TDP-43 accumulation is common in myopathies with rimmed vacuoles. Acta Neuropathol. 2009;117:209&#x2013;211. doi: 10.1007/s00401-008-0471-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0471-2</ArticleId><ArticleId IdType="pubmed">19066918</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno Y, Amari M, Takatama M, Aizawa H, Mihara B, Okamoto K. Immunoreactivities of p62, an ubiqutin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis. J Neurol Sci. 2006;249:13&#x2013;18. doi: 10.1016/j.jns.2006.05.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2006.05.060</ArticleId><ArticleId IdType="pubmed">16820172</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori Fumiaki, Miki Yasuo, Kon Tomoya, Tanji Kunikazu, Wakabayashi Koichi. Autophagy Is a Common Degradation Pathway for Bunina Bodies and TDP-43 Inclusions in Amyotrophic Lateral Sclerosis. Journal of Neuropathology &amp; Experimental Neurology. 2019;78(10):910&#x2013;921. doi: 10.1093/jnen/nlz072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlz072</ArticleId><ArticleId IdType="pubmed">31504678</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F, Tanji K, Kakita A, Takahashi H, Wakabayashi K. Enhancement of native and phosphorylated TDP-43 immunoreactivity by proteinase K treatment following autoclave heating. Neuropathology. 2011;31:401&#x2013;404. doi: 10.1111/j.1440-1789.2010.01184.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2010.01184.x</ArticleId><ArticleId IdType="pubmed">21175864</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F, Tanji K, Zhang HX, Nishihira Y, Tan CF, Takahashi H, Wakabayashi K. Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol. 2008;116:193&#x2013;203. doi: 10.1007/s00401-008-0396-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0396-9</ArticleId><ArticleId IdType="pubmed">18560845</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihira Y, Tan CF, Onodera O, Toyoshima Y, Yamada M, Morita T, Nishizawa M, Kakita A, Takahashi H. Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol. 2008;116:169&#x2013;182. doi: 10.1007/s00401-008-0385-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0385-z</ArticleId><ArticleId IdType="pubmed">18481073</ArticleId></ArticleIdList></Reference><Reference><Citation>Olive M, Janue A, Moreno D, Gamez J, Torrejon-Escribano B, Ferrer I. TAR DNA-binding protein 43 accumulation in protein aggregate myopathies. J Neuropathol Exp Neurol. 2009;68:262&#x2013;273. doi: 10.1097/NEN.0b013e3181996d8f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181996d8f</ArticleId><ArticleId IdType="pubmed">19225410</ArticleId></ArticleIdList></Reference><Reference><Citation>Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, Takahashi H. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson&#x2019;s disease. Brain. 2008;131:642&#x2013;650. doi: 10.1093/brain/awm302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm302</ArticleId><ArticleId IdType="pubmed">18079166</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandell S, Huovinen S, Palmio J, Raheem O, Lindfors M, Zhao F, Haapasalo H, Udd B. Diagnostically important muscle pathology in DNAJB6 mutated LGMD1D. Acta Neuropathol Commun. 2016;4:9. doi: 10.1186/s40478-016-0276-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0276-9</ArticleId><ArticleId IdType="pmc">PMC4743201</ArticleId><ArticleId IdType="pubmed">26847086</ArticleId></ArticleIdList></Reference><Reference><Citation>Soraru G, Orsetti V, Buratti E, Baralle F, Cima V, Volpe M, D'Ascenzo C, Palmieri A, Koutsikos K, Pegoraro E, et al. TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:240&#x2013;243. doi: 10.3109/17482960902810890.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902810890</ArticleId><ArticleId IdType="pubmed">19306141</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi R, Tada M, Shiga A, Toyoshima Y, Konno T, Sato T, Nozaki H, Kato T, Horie M, Shimizu H, et al. Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: evidence for clinico-pathologic subtypes. Acta Neuropathol Commun. 2016;4:61. doi: 10.1186/s40478-016-0335-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0335-2</ArticleId><ArticleId IdType="pmc">PMC4918136</ArticleId><ArticleId IdType="pubmed">27338935</ArticleId></ArticleIdList></Reference><Reference><Citation>Temiz P, Weihl CC, Pestronk A. Inflammatory myopathies with mitochondrial pathology and protein aggregates. J Neurol Sci. 2009;278:25&#x2013;29. doi: 10.1016/j.jns.2008.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2008.11.010</ArticleId><ArticleId IdType="pubmed">19101700</ArticleId></ArticleIdList></Reference><Reference><Citation>Turk M, Haaker G, Winter L, Just W, Nickel FT, Linker RA, Chevessier F, Schroder R. C9ORF72-ALS: P62- and ubiquitin-aggregation pathology in skeletal muscle. Muscle Nerve. 2014;50:454&#x2013;455. doi: 10.1002/mus.24283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24283</ArticleId><ArticleId IdType="pubmed">24817207</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogler TO, Wheeler JR, Nguyen ED, Hughes MP, Britson KA, Lester E, Rao B, Betta ND, Whitney ON, Ewachiw TE, et al. TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle. Nature. 2018;563:508&#x2013;513. doi: 10.1038/s41586-018-0665-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0665-2</ArticleId><ArticleId IdType="pmc">PMC6324568</ArticleId><ArticleId IdType="pubmed">30464263</ArticleId></ArticleIdList></Reference><Reference><Citation>Weihl CC, Pestronk A, Kimonis VE. Valosin-containing protein disease: inclusion body myopathy with Paget&#x2019;s disease of the bone and fronto-temporal dementia. Neuromuscul Disord. 2009;19:308&#x2013;315. doi: 10.1016/j.nmd.2009.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2009.01.009</ArticleId><ArticleId IdType="pmc">PMC2859037</ArticleId><ArticleId IdType="pubmed">19380227</ArticleId></ArticleIdList></Reference><Reference><Citation>Weihl CC, Temiz P, Miller SE, Watts G, Smith C, Forman M, Hanson PI, Kimonis V, Pestronk A. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2008;79:1186&#x2013;1189. doi: 10.1136/jnnp.2007.131334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2007.131334</ArticleId><ArticleId IdType="pmc">PMC2586594</ArticleId><ArticleId IdType="pubmed">18796596</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita S, Kimura E, Zhang Z, Tawara N, Hara K, Yoshimura A, Takashima H, Ando Y (2019) Muscle pathology of hereditary motor and sensory neuropathy with proximal dominant involvement with TFG mutation. Muscle Nerve. 10.1002/mus.26683</Citation><ArticleIdList><ArticleId IdType="pubmed">31449671</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>